Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C046062 |
2-thiomalic acid |
[Hydrogen Peroxide co-treated with 2-thiomalic acid] affects the localization of ENDOG protein | affects cotreatment|affects localization | 16407272
|
D000640 |
Amitrole |
Amitrole results in decreased activity of ENDOG protein | decreases activity | 16407272
|
D003513 |
Cycloheximide |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA] | decreases expression|decreases reaction | 11007951
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ENDOG mRNA | decreases expression | 20106945
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENDOG mRNA | affects cotreatment|increases expression | 17942748
|
D006861 |
Hydrogen Peroxide |
[Hydrogen Peroxide co-treated with 2-thiomalic acid] affects the localization of ENDOG protein | affects cotreatment|affects localization | 16407272
|
D007529 |
Isoflavones |
Isoflavones results in decreased expression of ENDOG mRNA | decreases expression | 17374662
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ENDOG mRNA | affects binding|decreases expression|increases activity | 19710929
|
C059514 |
resveratrol |
resveratrol affects the localization of ENDOG protein | affects localization | 16617056
|
D012643 |
Selenium |
Selenium results in increased expression of ENDOG mRNA | increases expression | 19244175
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of ENDOG mRNA | decreases expression | 12377979
|
D013749 |
Tetrachlorodibenzodioxin |
Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA] | decreases expression|decreases reaction | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of ENDOG mRNA | decreases expression | 11007951
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ENDOG mRNA | affects cotreatment|increases expression | 17942748
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of ENDOG mRNA | increases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
2.96 | 15322242 11752688 14514962 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.08 | 17505938 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
3.93 | 16538975 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.20 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.83 | 14692618 |
MESH:D000236 |
Adenoma |
|
resveratrol |
3.36 | 15688382 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
10.30 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
10.30 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.83 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.04 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.78 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
2.58 | 16162502 16183991 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.02 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.57 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
7.52 | 15885639 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
7.52 | 17115116 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
3.32 | 17967414 16873680 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.04 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.04 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.92 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.81 | 15746008 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
4.40 | 17600658 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
2.13 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.13 | 20435547 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.03 | 16050911 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.86 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
3.28 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.28 | 15276417 17306315 16507464 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
4.71 | 16675471 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
4.92 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.92 | 18572023 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.41 | 18670907 16120746 18850075 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
12.71 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
12.71 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
12.71 | 15458977 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
6.84 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
6.84 | 20056578 19524636 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.23 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
13.70 | 19486331 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
13.70 | 16919318 17110522 16105132 15861022 17681005 17333356 11677210 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
13.70 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.13 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D003092 |
Colitis |
|
resveratrol |
10.00 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
10.00 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
2.47 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
3.03 | 17116718 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
3.03 | 16550006 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.13 | 17141729 14669216 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.80 | 16507316 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.50 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
2.50 | 19769572 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.46 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
3.84 | 16873680 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.68 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
4.03 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
3.84 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.84 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.82 | 11462148 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
4.84 | 9068938 |
MESH:D004487 |
Edema |
|
pirinixic acid |
11.91 | 12083418 |
MESH:D004487 |
Edema |
|
resveratrol |
11.91 | 8985016 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
11.91 | 12711302 11000095 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.04 | 15322242 18230668 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
9.44 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
9.44 | 17872969 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.10 | 10568697 9294722 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.95 | 17923197 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.07 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
13.48 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
13.48 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
13.48 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.56 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
8.83 | 12168785 12639820 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
8.83 | 20067830 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.80 | 16452187 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
4.34 | 8708960 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.73 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.70 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
6.70 | 16080930 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
7.11 | 20558911 |
MESH:D006333 |
Heart Failure |
|
Selenium |
7.11 | 17162251 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.54 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.42 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
8.61 | 19772884 19176532 18467677 16221962 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
8.61 | 12621046 15340226 16120746 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.73 | 16490937 16863852 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
4.30 | 16876885 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.22 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
10.96 | 17290160 14716179 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
10.96 | 14716179 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.18 | 15340226 18606429 8697196 16959395 16354765 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
4.09 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.26 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
4.11 | 16873680 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
5.04 | 10903974 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
5.04 | 18850075 18670907 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
4.38 | 17488730 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
3.91 | 16945680 16569931 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
4.75 | 17600658 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.55 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
6.82 | 17937319 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.82 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
resveratrol |
5.20 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.20 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
19.45 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
19.45 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
19.45 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.68 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.42 | 16580747 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.58 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
10.35 | 8314463 10903974 18776723 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
10.35 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
10.35 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
10.30 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
10.30 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
2.80 | 12371664 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
3.63 | 16087638 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.45 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.45 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
3.45 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
10.94 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
10.94 | 20405173 19321006 19812893 19073162 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
10.94 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
10.94 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.15 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
7.62 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
7.62 | 16863852 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.45 | 15276417 16712894 19931552 17306315 17077188 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.45 | 11884234 19555203 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
3.45 | 11062179 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
4.39 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
3.94 | 14749477 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
4.36 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
6.39 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.39 | 15318939 |
MESH:D008545 |
Melanoma |
|
resveratrol |
3.54 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.54 | 16487513 19082730 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.82 | 15107826 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
4.46 | 17112576 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.92 | 16801185 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
3.52 | 16267019 16490592 14749477 17049120 17935668 17164350 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
4.99 | 17962980 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.61 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.84 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
5.84 | 17188708 16456233 16525036 17015251 16317513 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
9.23 | 17015251 17125593 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
9.23 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.01 | 16411023 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.88 | 17322642 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.07 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.07 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
9.58 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
9.58 | 20056578 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.58 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.36 | 19348381 18481113 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.31 | 14600291 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.19 | 12854658 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
3.87 | 17652729 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
4.49 | 17929310 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.83 | 20558911 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
4.15 | 16562857 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
4.34 | 17513867 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
2.46 | 15276417 17306315 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.77 | 11578682 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
4.19 | 12065085 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.38 | 12520081 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.02 | 15087411 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.65 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.29 | 12371664 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
9.99 | 16679765 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.99 | 11896295 11222880 11118676 11399792 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
2.14 | 17571952 17374662 17219775 16365062 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
2.14 | 16731767 17718901 17804756 15767336 17675339 17636462 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
2.14 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
2.14 | 15084515 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.43 | 16919318 15861022 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.25 | 16882103 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
5.72 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
6.70 | 19058328 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
6.70 | 16314181 17058453 17520802 16317513 15827377 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.93 | 18990726 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.46 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
13.90 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
13.90 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
13.90 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
13.90 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
4.08 | 16709447 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.86 | 12854658 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.58 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
4.56 | 16321402 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.71 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.22 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.04 | 12697716 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
4.29 | 16227395 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.53 | 16712894 16452187 17306315 11723127 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
9.82 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.82 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
9.82 | 14692618 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
9.82 | 17044934 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
4.12 | 1336536 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.54 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.73 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.62 | 15869587 14671159 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
4.41 | 17488730 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.38 | 15886252 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.58 | 17120751 |